Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.
Factors for treatment in lenvanitib group
| Factor | Low mG8 (n = 10) | High mG8 (n = 26) | p‐Value |
|---|---|---|---|
| Transition rate to posttreatment, n (%) | 4 (40.0) | 18 (78.3) | 0.049 |
| Discontinuation rate due to AEs, n (%) | 6 (60.0) | 10 (38.5) | 0.285 |
| 4W‐RDI, median (range) | 0.49 (0.07, 1.00) | 0.79 (0.02, 1.00) | 0.119 |
| Duration of medication, median (range) | 93.50 (4.00, 643) | 106.00 (1.00, 868) | 0.48 |
Abbreviation: 4W‐RDI: relative dose intensity during the initial 4 weeks of therapy.
